iProgen Biotech Inc.

Industry

  • Biotechnology
    • Drug Discovery Technologies
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
    • Drug Delivery
      • Site Specific
See more in Biomedtracker

Latest on iProgen Biotech Inc.

Scrip

Asia Deal Watch: ProGen To Partner With Rani On GLP-2 Agonist In Obesity

 
• By Joseph Haas, Jung Won Shin, and Lisa Takagi

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. ProGen Partners With Rani To Devel

Scrip

Next Potential Big ADC Player? Korean Firms Take It Up A Notch

 
• By Jung Won Shin

While the global biopharma industry saw lackluster deal-making activity in 2022, transactions involving antibody-drug conjugates (ADCs) continued to rise amid the global commercial success of Daiichi